All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ACET / Adicet Bio, Inc.
|
|
|
|
|
|
|
|
SPNE / SeaSpine Holdings Corp
|
|
|
|
|
|
|
|
ZNTL / Zentalis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
PHAS / PhaseBio Pharmaceuticals Inc
|
|
|
|
|
|
|
|
ERAS / Erasca, Inc.
|
|
|
|
|
|
|
|
SCYX / SCYNEXIS, Inc.
|
|
|
|
|
|
|
|
S / SentinelOne, Inc.
|
|
|
|
|
|
|
|
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
LSAQ / LifeSci Acquisition II Corp
|
|
|
|
|
|
|
|
XNTK / SPDR Series Trust - SPDR NYSE Technology ETF Call
|
|
|
|
|
|
|
|
IPSC / Century Therapeutics, Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
HSAQ / Health Sciences Acquisitions Corp 2
|
|
|
|
|
|
|
|
ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
BSX / Boston Scientific Corporation
|
|
|
|
|
|
|
|
NTLA / Intellia Therapeutics, Inc.
|
|
|
|
|
|
|
|
ISRG / Intuitive Surgical, Inc.
|
|
|
|
|
|
|
|
KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARWR / Arrowhead Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
CMPX / Compass Therapeutics, Inc.
|
|
|
|
|
|
|
|
ONCS / OncoSec Medical Inc
|
|
|
|
|
|
|
|
NKTX / Nkarta, Inc.
|
|
|
|
|
|
|
|
HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
SIBN / SI-BONE, Inc.
|
|
|
|
|
|
|
|
/ CareMax Inc
|
|
|
|
|
|
|
|
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
|
|
|
|
|
|
|
|
DYNS / Dynamics Special Purpose Corp Class A
|
|
|
|
|
|
|
|
ARYD / ARYA Sciences Acquisition Corp IV
|
|
|
|
|
|
|
|
DNAA / Social Capital Suvretta Holdings Corp I
|
|
|
|
|
|
|
|
DNAC / Social Capital Suvretta Holdings Corp III
|
|
|
|
|
|
|
|
TNGX / Tango Therapeutics, Inc.
|
|
|
|
|
|
|
|
DNAB / Social Capital Suvretta Holdings Corp II
|
|
|
|
|
|
|
|
31656R102 / Field Trip Health Ltd. (Canada)
|
|
|
|
|
|
|
|
KYG5960S1241 / Medicus Sciences Acquisition Corp.
|
|
|
|
|
|
|
|
NUVB / Nuvation Bio Inc.
|
|
|
|
|
|
|
|
ARKG / ARK ETF Trust - ARK Genomic Revolution ETF
|
|
|
|
|
|
|
|
EW / Edwards Lifesciences Corporation
|
|
|
|
|
|
|
|
VIR / Vir Biotechnology, Inc.
|
|
|
|
|
|
|
|
JNJ / Johnson & Johnson
|
|
|
|
|
|
|
|
DNAD / Social Capital Suvretta Holdings Corp IV - Class A
|
|
|
|
|
|
|
|
MSAC / Medicus Sciences Acquisition Corp - Class A
|
|
|
|
|
|
|
|
PANA / Panacea Acquisition Corp II - Class A
|
|
|
|
|
|
|
|
VRDN / Viridian Therapeutics, Inc.
|
|
|
|
|
|
|
|
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ANTX / AN2 Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYTT / Cyteir Therapeutics, Inc.
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
SMFR / Sema4 Holdings Corp - Class A
|
|
|
|
|
|
|
|
PEN / Penumbra, Inc.
|
|
|
|
|
|
|
|
EPIX / ESSA Pharma Inc.
|
|
|
|
|
|
|
|
BHC / Bausch Health Companies Inc.
|
|
|
|
|
|
|
|
ATEC / Alphatec Holdings, Inc.
|
|
|
|
|
|
|
|
APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BAX / Baxter International Inc.
|
|
|
|
|
|
|
|
MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
MCK / McKesson Corporation
|
|
|
|
|
|
|
|
ALT / Altimmune, Inc.
|
|
|
|
|
|
|
|
ARVN / Arvinas, Inc.
|
|
|
|
|
|
|
|
BLU / Bellus Health Inc
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
KZR / Kezar Life Sciences, Inc.
|
|
|
|
|
|
|
|
LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
GRTS / Gritstone bio, Inc.
|
|
|
|
|
|
|
|
INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
AVTR / Avantor, Inc.
|
|
|
|
|
|
|
|
AXSM / Axsome Therapeutics, Inc.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
ACHC / Acadia Healthcare Company, Inc.
|
|
|
|
|
|
|
|
ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
UNH / UnitedHealth Group Incorporated
|
|
|
|
|
|
|
|
SGEN / Seagen Inc
|
|
|
|
|
|
|
|
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
JAZZ / Jazz Pharmaceuticals plc
|
|
|
|
|
|
|
|
PHAT / Phathom Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
|
|
|
|
|
|
|
|
IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
GRPH / Graphite Bio, Inc.
|
|
|
|
|
|
|
|
HUM / Humana Inc.
|
|
|
|
|
|
|
|
ELV / Elevance Health, Inc.
|
|
|
|
|
|
|
|
CTLT / Catalent, Inc.
|
|
|
|
|
|
|
|
ISEE / IVERIC bio Inc
|
|
|
|
|
|
|
|
CRBU / Caribou Biosciences, Inc.
|
|
|
|
|
|
|
|
ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
HYPR / Hyperfine, Inc.
|
|
|
|
|
|
|
|
NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|